Abbott Respiratory Diagnostic Kit Recalled for Potential False Positive Results
Abbott Molecular is recalling the Alinity m Resp-4-Plex AMP Kit due to potential false positive results. The recall affects 5,855 units distributed worldwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification establishes a minimum severity of 4 per the recall rubric. Although no illnesses or injuries are reported in the source text, the potential for false positive results in a respiratory diagnostic device represents a serious risk to patient care through diagnostic error.
Plain-English summary
Abbott Molecular, Inc. is recalling the Alinity m Resp-4-Plex AMP Kit (Non-US Assay) and its Application Specification File. The FDA classified this as a Class I recall due to a potential for false positive results in respiratory virus testing.
The recall affects 5,855 units distributed worldwide across the United States, Australia, Austria, Belgium, Brazil, Canada, Colombia, Czech Republic, Estonia, Finland, France, Germany, Hong Kong, Ireland, Israel, Italy, Japan, Malaysia, Montenegro, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, United Kingdom, and Vietnam. Specific lot numbers and expiration dates have been identified by the FDA.
No illnesses or injuries have been reported in association with this issue. Laboratories and healthcare facilities using affected lots should contact Abbott Molecular for instructions on product replacement or corrective actions.
The recalled product
- Product
- Alinity m Resp-4-Plex AMP Kit (Non-US Assay) and Alinity m Resp-4-Plex Application Specification File. in vitro diagnostic
- Manufacturer
- Abbott Molecular, Inc.
- Hazard
- Affected units
- 5,855
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- List Number: 09N79-096
- UDI 00884999049390 Lot/Serial
- Expiration: 513424
- 10/13/2021
- 513771
- 513861
- 11/06/2021
- 514503
- 11/19/2021
- 515652
- 12/02/2021
- 516411
- 517877
- 518436
- 12/10/2021
- 518877
- 519091
- 519243
- 05/10/2022
- 519582
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 5 recalled by Abbott Molecular, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Abbott Molecular, Inc.
See all →- HighAbbott Alinity m Resp-4-Plex AMP Kit Multiplex PCR Test Recall
FDA (Devices) · 2025-05-21
- HighAbbott Alinity m Resp-4-Plex Amplification Kit Recall
FDA (Devices) · 2025-05-21
- ModerateAlinity m System nucleic acid testing instruments recalled for liquid spillage
FDA (Devices) · 2025-04-30
- HighAbbott STI and HPV Test Kits Recalled for Quality Control Failures
FDA (Devices) · 2024-11-06
- HighAbbott Alinity m HPV test kit control failures from iron contamination
FDA (Devices) · 2024-11-06
Same hazard · false positive
See all →- HighHealthmark ProChek-II Medical Tests Recalled for Expired Ingredient
FDA (Devices) · 2026-09-02
- HighAmyloid 1-42-N plasma calibrators recalled over falsely elevated results
FDA (Devices) · 2026-02-11
- HighpTau 217 plasma cartridges recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11
- HighpTau 217 plasma calibrators recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11
- HighAmyloid plasma controls recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11